A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

August 31, 2005

Conditions
Locally Advanced or Metastatic Adenoca of the Biliary Tract
Interventions
DRUG

OSI-7904L

DRUG

5-Fluorouracil/Leucovorin

Trial Locations (21)

1011

Multidisciplinary Oncology Center University Hospital CHUV, Lausanne

3400

Oncology Institute Ion Chiricuta, Cluj-Napoca

21287

Sidney Kimmel Comprehensive Cancer Center, Baltimore

37232

Vanderbilt Cancer Center, Nashville

43210

Division of Hematology/Oncology, Columbus

45122

Tumorforschung Innere Medizinische Klinik, Essen

48109

University of Michigan, Ann Arbor

48201

Wayne State University, Detroit

60611

Robert H. Lurie Comp. Cancer Ctr of Northwestern University, Chicago

Unknown

Institute Jules Bordet, 1000 Brussels

Dept Internal Medicine Gastrointestinal Oncology Unit, B-3000 Leuven

Department of Gastroenterology and GI Oncology, Brussels

Universitätsklinikum Charite Campus Virchow, 13353 Berlin

Allgemeines Krankenhaus St. Georg, 20099 Hamburg

Klinikum der J. W. Groethe-Universitat, 60590 Frankfurt

Innere Medizin Universitatsklinikum Heidelberg, 69115 Heidelberg

Medizinische Klinik II LMU-Klinikum-Großhadern, 81377 München

Klinika Nowotworow Gornego Odcinka, 02-791 Warszawa

Klinika Chemioterapii, 31-115 Krakow

Institutul Clinic Fundeni, 72437 Bucuresti

Oncosurgery University Hospital of Geneva, 1211 Geneva 14

Sponsors
All Listed Sponsors
lead

OSI Pharmaceuticals

INDUSTRY